GHP Investment Advisors’s Prestige Consumer Healthcare PBH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$3.55M Sell
75,121
-13,618
-15% -$700K 0.13% 188
2026
Q1
$5.26M Buy
88,739
+2,163
+2% +$140K 0.22% 143
2025
Q4
$5.34M Buy
86,576
+508
+0.6% +$31.1K 0.22% 143
2025
Q3
$5.37M Buy
86,068
+77
+0.1% +$5.36K 0.23% 142
2025
Q2
$6.87M Buy
85,991
+272
+0.3% +$22.8K 0.3% 121
2025
Q1
$7.37M Sell
85,719
-1,440
-2% -$118K 0.35% 103
2024
Q4
$6.81M Buy
87,159
+170
+0.2% +$13.2K 0.32% 117
2024
Q3
$6.27M Buy
86,989
+449
+0.5% +$31.8K 0.29% 132
2024
Q2
$5.96M Buy
86,540
+928
+1% +$62.9K 0.3% 124
2024
Q1
$6.21M Sell
85,612
-669
-0.8% -$44.7K 0.31% 117
2023
Q4
$5.28M Buy
86,281
+2,077
+2% +$123K 0.29% 128
2023
Q3
$5M Buy
84,204
+1,718
+2% +$104K 0.3% 114
2023
Q2
$5.33M Buy
82,486
+4,899
+6% +$293K 0.31% 111
2023
Q1
$4.86M Buy
77,587
+564
+0.7% +$35.2K 0.31% 118
2022
Q4
$4.82M Buy
77,023
+1,919
+3% +$110K 0.33% 112
2022
Q3
$3.74M Buy
75,104
+109
+0.1% +$6.04K 0.29% 125
2022
Q2
$4.41M Buy
74,995
+5,489
+8% +$303K 0.33% 117
2022
Q1
$3.68M Buy
69,506
+7,595
+12% +$439K 0.24% 142
2021
Q4
$3.75M Buy
61,911
+30,454
+97% +$1.81M 0.27% 132
2021
Q3
$1.76M Buy
31,457
+10,487
+50% +$576K 0.14% 181
2021
Q2
$1.09M Buy
20,970
+7,923
+61% +$381K 0.09% 191
2021
Q1
$575K Buy
+13,047
New +$548K 0.05% 224

Other funds holding PBH

GHP Investment Advisors's PBH Position: Q2 2026 in Review

GHP Investment Advisors reduced its Prestige Consumer Healthcare (PBH) stake by 15% in Q2 2026, selling an estimated $700K and leaving 75,121 shares worth $3.55M. The position accounts for 0.13% of the portfolio, ranked #188.

GHP Investment Advisors first reported a position in PBH in Q1 2021 and has held it in 22 quarters since. The position peaked at $7.37M in Q1 2025. 68 funds tracked by Wall St. Rank hold PBH as of Q2 2026.

  • GHP Investment Advisors held 75,121 shares of Prestige Consumer Healthcare worth $3.55M as of Q2 2026.
  • GHP Investment Advisors sold 13,618 Prestige Consumer Healthcare shares in Q2 2026, an estimated $700K.
  • Prestige Consumer Healthcare made up 0.13% of GHP Investment Advisors's portfolio in Q2 2026, its #188 holding.
  • GHP Investment Advisors first reported a position in Prestige Consumer Healthcare in Q1 2021 and has held it in 22 quarters since.
  • GHP Investment Advisors's Prestige Consumer Healthcare position peaked at $7.37M in Q1 2025.
  • 68 funds tracked by Wall St. Rank held Prestige Consumer Healthcare as of Q2 2026.

Based on GHP Investment Advisors's 13F filing for Q2 2026, filed 20 Jul 2026.